section name header

Y-Site Injection Compatibility (1:1 Mixture)

Labetalol HCl

(Mfr: k)(Conc: 2 mg/mLa)

QMark

Imipenem-cilastatin sodium-relebactam

(Mfr: ME)(Conc: 5 mg/mLl)

Remarks:

Visually compatible; pH increased by >1 unit within 1 hr

Ref:

3605